Short Interest in Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Grows By 28.5%

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) saw a significant growth in short interest in the month of January. As of January 15th, there was short interest totaling 2,256,450 shares, a growth of 28.5% from the December 31st total of 1,755,818 shares. Based on an average trading volume of 612,457 shares, the short-interest ratio is presently 3.7 days. Based on an average trading volume of 612,457 shares, the short-interest ratio is presently 3.7 days.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the stock. Zacks Research lowered shares of Fresenius Medical Care AG & Co. KGaA from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 4th. Truist Financial set a $28.00 price objective on shares of Fresenius Medical Care AG & Co. KGaA in a report on Monday, January 5th. Weiss Ratings cut shares of Fresenius Medical Care AG & Co. KGaA from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, January 5th. Wall Street Zen raised Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “strong-buy” rating in a research report on Saturday, December 20th. Finally, Morgan Stanley reaffirmed an “underweight” rating on shares of Fresenius Medical Care AG & Co. KGaA in a report on Tuesday, January 27th. Four analysts have rated the stock with a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and a consensus price target of $28.00.

Fresenius Medical Care AG & Co. KGaA Trading Down 0.6%

Shares of NYSE:FMS traded down $0.13 during trading on Monday, hitting $22.58. 430,741 shares of the company’s stock were exchanged, compared to its average volume of 681,934. The firm has a market cap of $13.09 billion, a P/E ratio of 16.48, a PEG ratio of 0.72 and a beta of 0.90. The firm has a 50-day moving average price of $23.15 and a two-hundred day moving average price of $24.64. The company has a current ratio of 1.36, a quick ratio of 1.00 and a debt-to-equity ratio of 0.45. Fresenius Medical Care AG & Co. KGaA has a 1-year low of $20.94 and a 1-year high of $30.46.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last posted its earnings results on Tuesday, November 4th. The company reported $0.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.59 by $0.05. Fresenius Medical Care AG & Co. KGaA had a return on equity of 7.42% and a net margin of 3.72%.The firm had revenue of $5.73 billion during the quarter, compared to analysts’ expectations of $4.72 billion. Equities analysts predict that Fresenius Medical Care AG & Co. KGaA will post 1.51 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in FMS. GAMMA Investing LLC increased its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 5.9% in the third quarter. GAMMA Investing LLC now owns 10,437 shares of the company’s stock worth $275,000 after purchasing an additional 585 shares during the period. Yousif Capital Management LLC grew its position in Fresenius Medical Care AG & Co. KGaA by 6.8% during the second quarter. Yousif Capital Management LLC now owns 9,804 shares of the company’s stock worth $280,000 after buying an additional 625 shares in the last quarter. Fifth Third Bancorp increased its stake in Fresenius Medical Care AG & Co. KGaA by 4.0% in the 4th quarter. Fifth Third Bancorp now owns 18,766 shares of the company’s stock worth $447,000 after acquiring an additional 726 shares during the last quarter. Russell Investments Group Ltd. increased its position in shares of Fresenius Medical Care AG & Co. KGaA by 21.3% in the second quarter. Russell Investments Group Ltd. now owns 5,096 shares of the company’s stock worth $146,000 after purchasing an additional 896 shares during the last quarter. Finally, PNC Financial Services Group Inc. raised its position in shares of Fresenius Medical Care AG & Co. KGaA by 11.7% during the 2nd quarter. PNC Financial Services Group Inc. now owns 10,161 shares of the company’s stock valued at $290,000 after buying an additional 1,068 shares in the last quarter. Institutional investors and hedge funds own 8.37% of the company’s stock.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.